Clinically Media’s Q3 Highlights

A Summer of Growth and Impact

As the summer months come to a close, we wanted to take a moment to reflect on what Clinically Media has been up to in Q3. It’s been a productive and fulfilling season, full of exciting projects and impactful partnerships. Here’s a look at some of the key initiatives we’ve been working on this summer.

Expanding Recruitment for Groundbreaking Studies

This summer, we’ve focused on driving recruitment for several critical clinical trials. Some of the key areas we’ve supported include:

  • Dermatology – acne, psoriasis, lip augmentation, melasma

  • Neurology – schizophrenia, social anxiety

  • Gastro – diabetes

Driving Innovation in Digital Patient Engagement

In addition to recruitment efforts, we’ve been hard at work refining our digital strategies for patient engagement. Clinically Media has been leveraging the latest in digital marketing technologies to ensure that we connect with the right patients at the right time. Some highlights include:

  • We have improved diversity in clinical trials through precise prescreening and advertising key word selection.

  • Our targeted social campaigns have seen tremendous success, particularly on platforms like Facebook and Instagram.

  • We focused on delivering value to patients by creating educational content that empowers patients to make informed decisions about participating in clinical trials (blog posts, infographics, and video explainers, all aimed at simplifying the clinical trial process).

 

Collaborating with Industry Leaders

We’ve strengthened partnerships with key players in the healthcare industry, working closely with pharmaceutical companies, CROs, and research organizations to streamline recruitment and improve patient outreach. These collaborations have been instrumental in improving the reach and impact of the studies we support.




Welcoming Patricia Walker, MD, PhD, to Our Advisory Team

This summer, we had the privilege of appointing Patricia Walker, MD, PhD, as an advisor. With her extensive expertise in dermatology and clinical research, Dr. Walker will provide invaluable insights as we continue to grow and support cutting-edge clinical trials.


Looking Ahead to Q4

A Season of Growth and New Opportunities

As we look forward to Q4, Clinically Media is excited about the opportunities ahead. We’re gearing up to launch several new recruitment initiatives that will support even more groundbreaking studies. Our focus will continue to be on connecting patients with life-changing clinical trials while expanding our reach through innovative digital strategies.

In Q4, we’re particularly excited to:

  • Launch Enhanced Patient Education Campaigns: Building on our success with content-driven outreach, we plan to roll out a series of campaigns for our clients designed to educate patients on the benefits of participating in clinical research, with a particular focus on underserved communities.

  • Strengthen Strategic Partnerships: We are actively seeking new partnerships with CROS, pharmaceutical companies, healthcare organizations, and technology providers to enhance our ability to recruit and engage patients across the globe.

  • Embrace Technology for Greater Impact: Q4 will see us further integrating advanced technologies into our patient recruitment efforts, from AI-driven screening to personalized communication strategies, all aimed at improving patient engagement and study enrollment rates.We are optimistic about the future and remain committed to our mission of helping patients access life-changing research opportunities. Here’s to an impactful and exciting Q4!




Previous
Previous

Welcoming Patricia Walker, MD, PhD, to Clinically Media’s Advisory Team

Next
Next

Victoria Donovan Named as PharmaVoice100 Honoree: Clinical Trial Guru